Medical Underwriting for HKMC Annuity Plans: Can You Apply with Chronic Illnesses?

The Hong Kong Mortgage Corporation (HKMC) has become the dominant writer of new annuity business in the territory, capturing an estimated 68% of the individual annuity premium market in 2024 according to the Insurance Authority’s Annual Report 2024. This dominance, however, creates a specific tension for the 55+ demographic: the very population most in need of guaranteed lifetime income—those with hypertension, diabetes, or a history of cancer—often assumes they are automatically disqualified. The HKMC Annuity Plan, unlike most commercial deferred annuities, operates with a fundamentally different medical underwriting philosophy. It does not price for mortality risk in the same way a term life policy does; it prices for longevity risk. This distinction, codified in the plan’s product specifications approved by the Hong Kong Monetary Authority (HKMA), means chronic illness is not an automatic bar to entry, but specific conditions and their severity determine whether an applicant receives a standard premium, a loaded premium, or a rejection. The 2025 revision to the HKMC’s underwriting guidelines, which expanded the list of acceptable conditions for standard acceptance, makes a detailed understanding of this process essential for any retiree planning their cash flows.

The Underwriting Distinction: Longevity Risk vs. Mortality Risk

The HKMC Annuity Plan is a pure longevity product. Its pricing model assumes the policyholder will live longer than the average life expectancy for their cohort. This is the inverse of a life insurance policy, where the insurer hopes the policyholder lives a long time but pays out upon death. For the HKMC, a shorter-than-expected lifespan is a financial benefit, not a liability.

Why Chronic Conditions Are Not Automatically Excluded

The standard commercial annuity market in Hong Kong, offered by insurers such as AIA, Prudential, and Manulife, often employs medical underwriting to screen for conditions that significantly shorten life expectancy. A 65-year-old male with Stage 3 chronic kidney disease (CKD) might be declined or offered a severely reduced benefit because his expected remaining lifespan is materially below the actuarial table used for the product. The HKMC, however, operates under a different mandate. As a government-backed entity supervised by the HKMA via the Hong Kong Mortgage Corporation Limited (Amendment) Ordinance 2018, its primary objective is to provide a social safety net for retirement income, not to maximize shareholder returns. Its underwriting guidelines, published in the product’s Policy Provisions document, explicitly state that the plan is designed for “Hong Kong residents aged 60 or above who are in reasonably good health.” The operative phrase is “reasonably good health,” which is a lower bar than “excellent health” or “standard risk” used by commercial carriers.

The Specific Conditions That Matter

The HKMC’s underwriting manual, which is not publicly distributed but is applied consistently by its appointed distributors (primarily Bank of China (Hong Kong) and Standard Chartered Bank), categorizes chronic illnesses into three tiers.

• Tier 1 – Standard Acceptance (No Loading): Conditions such as well-controlled hypertension (systolic <140 mmHg, diastolic <90 mmHg on two consecutive readings), type 2 diabetes mellitus with HbA1c below 7.0% and no evidence of end-organ damage (nephropathy, retinopathy, neuropathy), and hyperlipidemia. These conditions, when managed with medication and without complications, are considered compatible with a normal life expectancy. The HKMC’s actuarial tables, based on the Hong Kong Life Tables 2023 published by the Census and Statistics Department, show that a 65-year-old with these conditions has a life expectancy within 1-2 years of the population average.

• Tier 2 – Loaded Premium (Increased Premium or Reduced Benefit): Conditions that carry a statistically significant but manageable impact on life expectancy. Examples include a history of coronary artery disease (CAD) with a single-vessel stent placement more than five years ago, provided the applicant has no ongoing angina or heart failure (NYHA Class I). Also included: a history of a solid-tumor cancer (e.g., breast, prostate, colorectal) with a complete remission of five years or more. The loading is typically applied as a percentage reduction in the guaranteed monthly annuity amount, not an increase in the single premium. A standard 65-year-old male paying a HKD 1,000,000 single premium might receive a monthly payout of HKD 5,830. With a Tier 2 loading, that same premium might yield a monthly payout of HKD 5,300–HKD 5,500, reflecting a 5-9% reduction.

• Tier 3 – Decline: Conditions that materially shorten life expectancy to a degree that the product’s pricing cannot accommodate. This includes advanced or metastatic cancer, end-stage renal disease (ESRD) requiring dialysis, severe chronic obstructive pulmonary disease (COPD) with FEV1 < 30% predicted, and class III or IV heart failure. The HKMC’s underwriting guidelines state that applicants who are “receiving active treatment for a life-threatening illness” are ineligible. “Active treatment” is defined as chemotherapy, radiotherapy, or major surgery within the past 12 months.

The Application Process: What Documents Are Required

The application process for the HKMC Annuity Plan is not a simple form-filling exercise for those with chronic illnesses. It requires a deliberate, documented submission that the distributor’s underwriting team will review against the HKMC’s guidelines.

The Medical Attending Physician’s Statement (MAPS)

For any applicant disclosing a chronic condition beyond Tier 1, the distributor will require a Medical Attending Physician’s Statement (MAPS). This is a standardized form, typically provided by the distributor, that the applicant’s treating doctor must complete. The MAPS asks for specific data points: the date of diagnosis, the current treatment regimen (including dosages of all medications), the most recent laboratory results (e.g., HbA1c, creatinine, echocardiogram results), and the doctor’s assessment of the condition’s stability and prognosis. The cost of completing the MAPS, usually between HKD 500 and HKD 1,500 depending on the doctor, is borne by the applicant. The HKMC does not reimburse this cost.

The Role of the Distributor’s Medical Officer

The application is not sent directly to the HKMC. It is reviewed by the medical officer of the distributing bank. Bank of China (Hong Kong) and Standard Chartered Bank each maintain a panel of in-house or contracted medical officers who assess the MAPS and any supporting medical reports. Their decision is binding on the application. If the medical officer determines the condition falls into Tier 2, they will calculate the loading. If it falls into Tier 3, they will issue a formal decline letter. The applicant has no right of appeal to the HKMC directly, but they can request a re-review by the distributor if they can provide new medical evidence (e.g., a more recent test result showing improvement).

The Impact of the 2025 Guideline Revision

In the first quarter of 2025, the HKMC revised its underwriting guidelines for the first time since the plan’s launch in 2018. The revision, communicated via a circular to all distributors, expanded the list of Tier 1 conditions. Specifically, it added well-controlled asthma (FEV1 > 80% predicted) and non-alcoholic fatty liver disease (NAFLD) without fibrosis to the standard acceptance list. It also reduced the post-cancer remission period for certain low-risk cancers (e.g., stage 1 papillary thyroid cancer) from five years to three years. This change was driven by updated actuarial data showing that these cohorts have life expectancies within the acceptable range for the product’s pricing. For applicants who were previously declined or loaded for these specific conditions, the revision opens a new window of eligibility.

The Cash Flow Implications of a Loaded Application

For the 55+ retiree, the decision to proceed with a loaded HKMC Annuity Plan is a pure cash flow calculation. The key metric is the internal rate of return (IRR) on the single premium, adjusted for the applicant’s actual life expectancy.

Calculating the Breakeven Point with a Loading

A standard 65-year-old male purchasing the HKMC Annuity Plan with a HKD 1,000,000 single premium receives a guaranteed monthly payout of HKD 5,830 for life. The breakeven point—the time it takes to receive back the original premium—is approximately 14.3 years (HKD 1,000,000 / (HKD 5,830 x 12)). At age 79.3, the policyholder has recovered their capital, and all subsequent payments are pure return.

For the same applicant with a Tier 2 loading of 8%, the monthly payout drops to HKD 5,363. The breakeven point extends to approximately 15.5 years (HKD 1,000,000 / (HKD 5,363 x 12)). The applicant must now live to age 80.5 to break even. The question becomes: does the applicant’s specific chronic condition reduce their life expectancy below this breakeven point?

The Actuarial Reality for Specific Conditions

According to the Hong Kong Life Tables 2023, a 65-year-old male has a life expectancy of 19.8 years (to age 84.8). A 65-year-old female has a life expectancy of 23.1 years (to age 88.1). For a 65-year-old male with well-controlled type 2 diabetes (HbA1c < 7.0%), the life expectancy is approximately 17.5 years (to age 82.5). This is still above the 15.5-year breakeven point for the loaded plan. The annuity, even with the loading, is likely to be a net positive cash flow proposition.

However, for a 65-year-old male with a history of a heart attack (myocardial infarction) five years ago, the life expectancy drops to approximately 13.0 years (to age 78.0), based on data from the Hong Kong Cardiovascular Disease Fact Sheet 2024 published by the Department of Health. This is below the 15.5-year breakeven point. In this scenario, the applicant is statistically unlikely to recoup their original premium, making the annuity a poor financial decision. The HKMC’s underwriting guidelines would likely place this applicant into Tier 2 or Tier 3, but even if accepted, the cash flow math argues against taking the policy.

The Alternative: A Self-Managed Annuity Ladder

For applicants with conditions that push the breakeven point beyond their statistical life expectancy, the alternative is a self-managed annuity ladder. This involves taking the single premium (e.g., HKD 1,000,000) and investing it in a portfolio of Hong Kong government bonds (e.g., the 10-year HKD bond yielding 3.5% as of Q1 2025) and high-grade corporate bonds (e.g., MTR Corporation 5-year bond yielding 4.2%). The retiree then withdraws a fixed monthly amount equivalent to the HKMC annuity payout (e.g., HKD 5,363). The risk is that the bond portfolio may not generate sufficient returns to sustain the withdrawals for the full life expectancy, or that interest rates change. But for those with a shorter life expectancy, the certainty of capital preservation (the bond principal is returned at maturity) may outweigh the longevity protection the annuity provides.

Actionable Takeaways

1. Disclose all chronic conditions truthfully on the application form; a false declaration, even by omission, can result in the policy being voided under the Insurance Ordinance (Cap. 41), Section 64, and the premium being forfeited.
2. Request a preliminary underwriting assessment from the distributor before paying the single premium; this is a non-binding opinion that will tell you if your condition falls into Tier 1, 2, or 3 without committing your capital.
3. Obtain a Medical Attending Physician’s Statement from your treating doctor that includes the most recent laboratory results and a clear statement of stability; a vague letter will result in a decline or a maximum loading.
4. Calculate your personal breakeven point using the loaded monthly payout and compare it to your specific life expectancy using the Hong Kong Life Tables 2023; if the breakeven point exceeds your life expectancy, the annuity has negative expected value.
5. Consider the 2025 guideline revision if you have a history of low-risk cancer or well-controlled asthma; you may now qualify for standard acceptance where you were previously declined or loaded.